Changing the course of disease
Translating scientific knowledge into health care practice and delivery
Think of them as medical middlemen—the researchers who take cutting-edge scientific discoveries and translate them into therapies that your doctor can use. At WSU, these experts develop novel therapies and vaccines. They devise different methods of delivering drugs to make them more potent weapons against disease. They determine which exercise and nutrition strategies yield the best results.
Since each of us is unique, WSU scientists seek to understand the fundamental biological makeup of individuals. That knowledge will allow them to tailor therapies to achieve the greatest possible benefit.
WSU researchers apply fundamental knowledge to change the course of disease. They help doctors achieve better outcomes for patients like you.
- Novel therapeutic strategies
- Pharmacogenomics and individualized therapies
- Innovative solutions to infectious disease
The uncompromising pursuit of healthier people and communities
Addressing health disparities and preventing disease
American Indian, Alaska Native, Native Hawaiian, and Pacific Islander communities experience elevated rates of hypertension, cardiovascular disease, and stroke. These communities are historically underserved when it comes to health care. Little research has been conducted to better understand and address their health care needs.
Dr. Dedra Buchwald of the WSU Health Sciences Spokane campus hopes to equip these communities with powerful tools to improve blood pressure control, and ultimately cardiovascular disease and stroke. With a $10 million grant from the National Institute on Minority Health and Health Disparities, Dr. Buchwald will work with a Southwest tribe, an Alaska Native health … » More …Read Story
Predicting the Progression of Cancers
Pharmacy research paves way for genetic tests
Physicians may soon have another diagnostic tool to help treat cancer patients, thanks to a new partnership between WSU and a genetic testing company based in India. Under a recently signed licensing agreement, Datar Genetics Ltd. will use a set of genes identified by College of Pharmacy researchers to develop tests to predict prostate cancer recurrence and breast cancer survival. The partnership was facilitated by the WSU Office of Commercialization, which is looking for additional licensing partners in other countries.
The research that led to the identification of the 20 genes was conducted in the lab of Grant Trobridge, … » More …Read Story
Finding treatment for genetic disorders
Experimental drug could help children with a rare inherited condition
A rare inherited disorder that afflicts children, succinic semialdehyde dehydrogenase deficiency (SSADHD) is a defect in GABA metabolism that mimics autism and epilepsy. It triggers seizures, low muscle tone, developmental delays, and a host of neurological problems. There is no treatment beyond simply managing seizures and other symptoms.
SSADHD is caused by a mutation in a single gene that leaves a critical enzyme in short supply. K. Michael Gibson, a board-certified clinical biochemical geneticist and director of the Experimental and Systems Pharmacology Unit in the College of Pharmacy, discovered the enzyme defect during … » More …Read Story
Preventing sensory loss
Study explores ways to safeguard fragile cells in the inner ear
It doesn’t take much to damage the delicate sensory cells of the inner ear—loud noises, a toxin, or even a life-saving antibiotic can damage or kill the minuscule hair cells that convert acoustic signals to electrochemical signals in the nervous system. If too many of these fragile cells die, hearing dies with them.
WSU researcher Allison Coffin, of the University’s Department of Integrative Physiology and Neuroscience, wants to make sure this doesn’t happen.
With funding from the National Institute of Health and the Action on Hearing Loss Foundation, Dr. Coffin is exploring ways … » More …Read Story